Public COA audit

Tesamorelin · Ipamorelin

Audited September 5, 2026

Incomplete documentation

Missing panels or key metadata — not enough evidence to treat this as a full certificate.

Legitimacy
45
Confidence
75%
Panels
0/7

Scored poorly because the file is incomplete or not a full COA, limited panel coverage (0/7), 3 critical findings, and notable note: "No analytical panels present". To improve: upload the full certificate (or the matching sibling purity/endotoxin report) and include identity, purity, and endotoxin at minimum.

Document details

Fields extracted from the certificate — not order or payment data.

Batch / lot
2X+15N061825
Sample date
2025-06-24
Issue date
2025-06-26

Original certificate

Embedded copy of the stored COA PDF or image. Download it for your records — PeptIQ’s audit is separate from the lab document itself.

Loading original certificate…

7-panel checklist

Had data + good, had data + bad, reported without pass/fail, or missing. Missing lowers thoroughness — you decide whether that panel matters; PeptIQ’s score still factors coverage.

0 of 7 present · 0 passed · 0 failed · 0 reported · 7 missing

Missing is a thoroughness gap — not automatically bad. PeptIQ’s legitimacy score still weighs panel coverage; you can down-weight panels that don’t matter for your use case.

  • Identity

    Not on this certificate file · core

    Compound identity confirmed (e.g. HPLC, mass spec).

    No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”

  • Purity

    Not on this certificate file · core

    Reported purity percentage for the analyte.

    No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”

  • Heavy metals

    Not on this certificate file

    Lead, arsenic, cadmium, mercury, or similar limits.

    No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”

  • Microbial

    Not on this certificate file

    Bioburden / microbial limits testing.

    No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”

  • Endotoxin

    Not on this certificate file · core

    LAL or chromogenic endotoxin assay.

    No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”

  • Sterility

    Not on this certificate file

    Sterility testing where applicable.

    No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”

  • Residual solvent / water

    Not on this certificate file

    Residual solvents or water content limits.

    No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”

How to read this

Had data · good

Panel present with a pass (or clear acceptance).

Had data · bad

Panel present with a fail — a concrete quality signal.

Had data · unclear

Value reported without an explicit pass/fail mark.

Missing on this file

Not on this certificate file. Lowers file thoroughness; a sibling endotoxin/purity report for the same lot may still exist. PeptIQ’s score still factors coverage.

Findings

Evidence-linked observations from this audit.

  • No analytical panels present

    This report shows only mass measurements (mg) for Tesamorelin and Ipamorelin in triplicate, but provides no purity percentage, identity confirmation (MS/HPLC), or safety panels (endotoxin, heavy metals, microbial, sterility). This is a quantitative assessment of vial contents, not a comprehensive COA.

  • No purity data

    Document states 'Assessment of a peptide vial or vials' but provides only mass quantities (11.37 mg, 11.32 mg, 11.28 mg for Tesamorelin; 6.15 mg, 6.09 mg, 6.12 mg for Ipamorelin). No HPLC purity percentage or chromatogram is shown.

  • No identity confirmation

    No mass spectrometry, HPLC retention time, or other identity verification method is documented. The report assumes the compounds are as labeled but does not confirm their chemical identity.

  • Batch number present

    Batch 2X+15N061825 is clearly stated.

  • Dates are valid and consistent

    Testing ordered 21 JUN '25, sample received 24 JUN '25, analysis conducted 26 JUN 2025. All dates are sequential and on or before 2026-09-05.

  • Known testing lab

    Janoshik is a recognized third-party analytical lab in the peptide/performance-enhancing substance community. Contact info and verification URL are provided.

  • Limited scope document

    This appears to be a mass quantitation report only, not a full COA. The 'Tests requested' section states 'Assessment of a peptide vial or vials' which is vague and does not specify comprehensive analytical testing.

Timing & next steps

Practical follow-ups based on document age and gaps.

  • coa age

    This COA was issued over a year ago (436 days) — consider whether a retest is warranted for this batch.

PeptIQ COA reports analyze document content and publicly verifiable lab signals. They are educational and not a guarantee of product quality, legality, or safety. Always consult a qualified professional before making health decisions. We never publish purchase prices, shipping details, or uploader identity.